Basel Medical Group Ltd (BMGL)

Basel Medical Group Cash Flow Statement

Financials in millions SGD. Fiscal year is July - June.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022
Net Income	-12.51	2.4	2.13	2.13
Depreciation & Amortization	1.18	0.53	0.6	0.6
Other Adjustments	11.08	0.17	0.1	0.1
Change in Receivables	-7.28	-0.42	0.54	0.54
Changes in Inventories	-0.3	0.02	-0.02	-0.02
Changes in Accounts Payable	4.34	0.39	-0.22	-0.22
Changes in Other Operating Activities	-0.85	-0.59	-0.52	-0.52
Operating Cash Flow	-4.34	2.51	2.6	2.6
Operating Cash Flow Growth	-	-3.49%	-	-
Capital Expenditures	-0.05	-0.01	-0.01	-0.01
Payments for Business Acquisitions	-10.99	-	-	-
Other Investing Activities	-0	-	-	-
Investing Cash Flow	-11.04	-0.01	-0.01	-0.01
Long-Term Debt Issued	4	-	-	-
Long-Term Debt Repaid	-8.26	-2.36	-2.32	-2.32
Net Long-Term Debt Issued (Repaid)	-4.26	-2.36	-2.32	-2.32
Issuance of Common Stock	9.75	-	-	-
Net Common Stock Issued (Repurchased)	9.75	-	-	-
Other Financing Activities	11.42	0.59	-0.62	-0.62
Financing Cash Flow	16.91	-1.77	-2.94	-2.94
Effect of Exchange Rate Changes on Cash and Cash Equivalents	-0.5	-	-	-
Net Cash Flow	1.52	0.73	-0.35	-0.35
Free Cash Flow	-4.4	2.5	2.59	2.59
Free Cash Flow Growth	-	-3.56%	-	-
FCF Margin	-38.86%	24.89%	26.74%	24.34%
Free Cash Flow Per Share	-0.23	0.15	0.16	0.16
Levered Free Cash Flow	-24.13	2.13	-0.71	0.3
Unlevered Free Cash Flow	18.52	20.8	20.12	22.27

Updated Jun 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q